202 related articles for article (PubMed ID: 21339212)
1. Targeting inflammation by modulating the Jun/AP-1 pathway.
Schonthaler HB; Guinea-Viniegra J; Wagner EF
Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i109-12. PubMed ID: 21339212
[TBL] [Abstract][Full Text] [Related]
2. Signalling in inflammatory skin disease by AP-1 (Fos/Jun).
Uluçkan Ö; Guinea-Viniegra J; Jimenez M; Wagner EF
Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S44-9. PubMed ID: 26458100
[TBL] [Abstract][Full Text] [Related]
3. Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun).
Wagner EF
Ann Rheum Dis; 2010 Jan; 69 Suppl 1():i86-88. PubMed ID: 19995753
[TBL] [Abstract][Full Text] [Related]
4. Jun signalling in the epidermis: From developmental defects to psoriasis and skin tumors.
Zenz R; Wagner EF
Int J Biochem Cell Biol; 2006; 38(7):1043-9. PubMed ID: 16423552
[TBL] [Abstract][Full Text] [Related]
5. Role of IL-17A signalling in psoriasis and associated bone loss.
Uluçkan Ö; Wagner EF
Clin Exp Rheumatol; 2016; 34(4 Suppl 98):17-20. PubMed ID: 27586798
[TBL] [Abstract][Full Text] [Related]
6. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins.
Zenz R; Eferl R; Kenner L; Florin L; Hummerich L; Mehic D; Scheuch H; Angel P; Tschachler E; Wagner EF
Nature; 2005 Sep; 437(7057):369-75. PubMed ID: 16163348
[TBL] [Abstract][Full Text] [Related]
7. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
8. From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance.
Karin M; Gallagher E
IUBMB Life; 2005; 57(4-5):283-95. PubMed ID: 16036612
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB mediates MPP+-induced apoptotic cell death in neuroblastoma cells SH-EP1 through JNK and c-Jun/AP-1.
Yang HJ; Wang L; Xia YY; Chang PN; Feng ZW
Neurochem Int; 2010 Jan; 56(1):128-34. PubMed ID: 19778565
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo.
Fisher GJ; Talwar HS; Lin J; Lin P; McPhillips F; Wang Z; Li X; Wan Y; Kang S; Voorhees JJ
J Clin Invest; 1998 Mar; 101(6):1432-40. PubMed ID: 9502786
[TBL] [Abstract][Full Text] [Related]
11. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G
Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913
[TBL] [Abstract][Full Text] [Related]
12. Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical vein endothelial cells.
Lee CC; Chen SC; Tsai SC; Wang BW; Liu YC; Lee HM; Shyu KG
J Biomed Sci; 2006 Jan; 13(1):143-56. PubMed ID: 16328781
[TBL] [Abstract][Full Text] [Related]
13. Wnt-3a regulates chondrocyte differentiation via c-Jun/AP-1 pathway.
Hwang SG; Yu SS; Lee SW; Chun JS
FEBS Lett; 2005 Aug; 579(21):4837-42. PubMed ID: 16099458
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P4502E1- and cytochrome P4502B1/2B2-catalyzed carbon tetrachloride metabolism: effects on signal transduction as demonstrated by altered immediate-early (c-Fos and c-Jun) gene expression and nuclear AP-1 and NF-kappa B transcription factor levels.
Gruebele A; Zawaski K; Kaplan D; Novak RF
Drug Metab Dispos; 1996 Jan; 24(1):15-22. PubMed ID: 8825185
[TBL] [Abstract][Full Text] [Related]
15. Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin.
Johansen C; Kragballe K; Rasmussen M; Dam TN; Iversen L
Br J Dermatol; 2004 Sep; 151(3):600-7. PubMed ID: 15377346
[TBL] [Abstract][Full Text] [Related]
16. Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model.
Cooper SJ; MacGowan J; Ranger-Moore J; Young MR; Colburn NH; Bowden GT
Mol Cancer Res; 2003 Sep; 1(11):848-54. PubMed ID: 14517347
[TBL] [Abstract][Full Text] [Related]
17. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
[TBL] [Abstract][Full Text] [Related]
18. Regulation of interleukin-1 and tumor necrosis factor-alpha induced granulocyte-macrophage colony-stimulating factor gene expression: potential involvement of arachidonic acid metabolism.
Rizzo MT; Boswell HS
Exp Hematol; 1994 Jan; 22(1):87-94. PubMed ID: 8282065
[TBL] [Abstract][Full Text] [Related]
19. Suppression of the c-Jun N-terminal kinase pathway by 17beta-estradiol can preserve human islet functional mass from proinflammatory cytokine-induced destruction.
Eckhoff DE; Smyth CA; Eckstein C; Bilbao G; Young CJ; Thompson JA; Contreras JL
Surgery; 2003 Aug; 134(2):169-79. PubMed ID: 12947315
[TBL] [Abstract][Full Text] [Related]
20. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter.
Thomas RS; Tymms MJ; McKinlay LH; Shannon MF; Seth A; Kola I
Oncogene; 1997 Jun; 14(23):2845-55. PubMed ID: 9190901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]